143 results on '"Molitoris, Jason K."'
Search Results
2. Conditional Risk and Predictive Factors Associated With Late Toxicity in Patients With Prostate Cancer Treated With External Beam Radiation Therapy Alone in the Randomized Trial RTOG 0126
3. Racial Analysis of Clinical and Biochemical Outcomes in Patients With Prostate Cancer Treated With Low-Dose-Rate Brachytherapy
4. Radiation Therapy and Malignant Fistulae of Anorectal Cancers
5. Estimating survival for renal cell carcinoma patients with brain metastases: an update of the Renal Graded Prognostic Assessment tool.
6. Effect of Targeted Therapies on Prognostic Factors, Patterns of Care, and Survival in Patients With Renal Cell Carcinoma and Brain Metastases
7. Estimating Survival in Melanoma Patients With Brain Metastases: An Update of the Graded Prognostic Assessment for Melanoma Using Molecular Markers (Melanoma-molGPA).
8. The Prognostic Value of BRAF, C-KIT, and NRAS Mutations in Melanoma Patients With Brain Metastases.
9. Is noncoplanar plan more robust to inter‐fractional variations than coplanar plan in treating bilateral HN tumors with pencil‐beam scanning proton beams?
10. Assessing Outcomes of Patients Treated With Re-Irradiation Utilizing Proton Pencil-Beam Scanning for Primary or Recurrent Malignancies of the Esophagus and Gastroesophageal Junction
11. Optimal Target Delineation and Treatment Techniques in the Era of Conformal Photon and Proton Breast and Regional Nodal Irradiation
12. Defining Optimal Target Volumes of Conformal Radiation Therapy for Diffuse Intrinsic Pontine Glioma
13. The Utility of PET/Computed Tomography for Radiation Oncology Planning, Surveillance, and Prognosis Prediction of Gastrointestinal Tumors
14. A multi-institutional analysis of clinical outcomes and patterns of care of 1p/19q codeleted oligodendrogliomas treated with adjuvant or salvage radiation therapy
15. Patterns of Care and Survival in Stage III NSCLC Among Black and Latino Patients Compared With White Patients
16. Lymph Node Size Predicts for Asymptomatic Brain Metastases in Patients With Non–small-cell Lung Cancer at Diagnosis
17. Long-term outcomes analysis of low-dose-rate brachytherapy in clinically T3 high-risk prostate cancer
18. Trends in utilization of hypofractionated whole breast irradiation (HF-WBI) in triple negative breast cancer (TNBC): a national cancer database (NCDB) analysis
19. Immune checkpoint inhibition in patients treated with stereotactic radiation for brain metastases
20. The Role of Radiation Therapy for Pancreatic Cancer in the Adjuvant and Neoadjuvant Settings
21. Proton Beam Therapy in Liver Malignancies
22. Post-treatment PET/CT for p16-positive oropharynx cancer treated with definitive proton therapy.
23. Factors Influencing Management and Outcome in Patients with Occult Breast Cancer with Axillary Lymph Node Involvement: Analysis of the National Cancer Database
24. Increasing utilization of regional nodal irradiation in elderly node-positive women and declining emphasis on demographic factors
25. Multi-institutional external validation of a novel glioblastoma prognostic nomogram incorporating MGMT methylation
26. Utilization of hypofractionated whole-breast radiation therapy in patients receiving chemotherapy: a National Cancer Database analysis
27. Gross tumor volume margin and local control in p16‐positive oropharynx cancer patients treated with intensity modulated proton therapy.
28. How many brain metastases can be treated with stereotactic radiosurgery before the radiation dose delivered to normal brain tissue rivals that associated with standard whole brain radiotherapy?
29. Proton beam stereotactic body radiotherapy and hypofractionated therapy with pencil beam scanning is safe and effective for advanced hepatocellular carcinoma and intrahepatic cholangiocarcinoma: A single center experience.
30. Regionalization of Head and Neck Oncology Tumor Boards: Perspectives of Collaborating Physicians.
31. Evaluation of intrafraction couch shifts for proton treatment delivery in head‐and‐neck cancer patients: Toward optimal imaging frequency.
32. Functional Imaging of Liver Cancer (FLIC): Study protocol of a phase 2 trial of 18F-DCFPyL PET/CT imaging for patients with hepatocellular carcinoma.
33. 227 Early outcomes for a single-arm, single-stage phase I/II trial of Selective Avoidance of nodalVolumEs at minimal Risk (SAVER) in the contralateral neck of patients with p16-positiveoropharynx cancer.
34. Induction of Ca2+-driven apoptosis in chronic lymphocytic leukemia cells by peptide-mediated disruption of Bcl-2–IP3 receptor interaction
35. Genomic biomarkers to guide precision radiotherapy in prostate cancer.
36. Start Combining, Stop Comparing
37. Impact of the Novel Coronavirus 2019 (COVID-19) Pandemic on Head and Neck Cancer Care.
38. Acute Effects of Fractional Laser on Photo-Aged Skin
39. Glucocorticoid-Mediated Repression of the Oncogenic microRNA Cluster miR-17∼92 Contributes to the Induction of Bim and Initiation of Apoptosis
40. Executive Summary of Clinical and Technical Guidelines for Esophageal Cancer Proton Beam Therapy From the Particle Therapy Co-Operative Group Thoracic and Gastrointestinal Subcommittees.
41. Selection of Mediastinal Lymphoma Patients for Proton Therapy Within the Proton Collaborative Group Registry: Concordance With the ILROG Guidelines.
42. High-risk, recurrent and oligometastatic prostate cancer: recent developments on the role of radiation.
43. PO36: Racial Analysis of Freedom from Biochemical Failure in Prostate Cancer Patients Treated with Low-Dose-Rate Brachytherapy Alone
44. PO16: Clinical Outcomes of HDR Brachytherapy with Concurrent Interstitial Hyperthermia for Gynecologic Malignancies
45. Conditional Risks of Biochemical Failure and Prostate Cancer–Specific Death in Patients Undergoing External Beam Radiotherapy: A Secondary Analysis of 2 Randomized Clinical Trials.
46. Phase 2 randomized total eradication of metastatic lesions following definitive radiation to the prostate in de novo oligometastatic prostate cancer (TERPs) trial.
47. Genomic determinants of patterns of failure in metachronous oligometastatic castration-sensitive prostate cancer.
48. Prognostic impact of circulating tumor cells in oligometastatic hormone-sensitive prostate cancer following metastasis-directed therapy.
49. (S001) Regional Nodal Irradiation in Elderly Node Positive Women: A Patterns of Care Study on Changes in Utilization Over a Decade
50. Whole-Brain Radiation in the Treatment of Brain Metastases in ALK-Positive Non-Small-Cell Lung Cancer.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.